These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32335060)

  • 1. Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.
    Tully KH; Roghmann F; Noldus J; Chen X; Häuser L; Kibel AS; Sonpavde GP; Mossanen M; Trinh QD
    Clin Genitourin Cancer; 2020 Dec; 18(6):e651-e659. PubMed ID: 32335060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radical cystectomy in patients with pathological non-muscle invasive bladder cancer].
    Hao H; Su XH; Zheng W; Ge P; He Q; Shen Q; Yang XY; Zhang Z; Li XS; Lin J; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):627-631. PubMed ID: 29263502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
    Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
    Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
    Bruins HM; Skinner EC; Dorin RP; Ahmadi H; Djaladat H; Miranda G; Cai J; Daneshmand S
    Urol Oncol; 2014 Jan; 32(1):24.e13-9. PubMed ID: 23395238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
    Lonati C; Afferi L; Mari A; Minervini A; Krajewski W; Borghesi M; Schulz GB; Rink M; Montorsi F; Briganti A; Colombo R; Martini A; Necchi A; Contieri R; Hurle R; Umari P; Zamboni S; Simeone C; Soria F; Marra G; Gontero P; Teoh JY; Klatte T; Bajeot AS; Roumiguié M; Rouprêt M; Masson-Lecomte A; Laukhtina E; Valiquette AS; Mir MC; Antonelli A; Einerhand SMH; Hendricksen K; Carando R; Fankhauser CD; Baumeister P; Mattei A; Shariat SF; Moschini M;
    World J Urol; 2022 May; 40(5):1167-1174. PubMed ID: 35218372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
    Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
    Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?
    Tully KH; Cole AP; Krimphove MJ; Friedlander DF; Mossanen M; Herzog P; Noldus J; Sonpavde GP; Trinh QD
    Urology; 2021 Jan; 147():199-204. PubMed ID: 32805294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy.
    Dursun F; Elshabrawy A; Wang H; Wu S; Liss MA; Kaushik D; Grosser D; Svatek RS; Mansour AM
    Urol Oncol; 2022 Jun; 40(6):275.e1-275.e10. PubMed ID: 35351370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.
    Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT
    Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience.
    Khanna A; Miest T; Sharma V; Campbell R; Hensley P; Thapa P; Zganjar A; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Murthy PB; Haber GP; Navai N; Kamat AM; Dinney C; Lee B; Boorjian SA
    J Urol; 2022 Mar; 207(3):551-558. PubMed ID: 34694143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study.
    Zheng Y; Ye Y; Chen J; Wei Z; Liu Z; Yu K; Zhang X
    Int J Surg; 2022 Jul; 103():106693. PubMed ID: 35690361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of robot-assisted vs. open radical cystectomy.
    Hanna N; Leow JJ; Sun M; Friedlander DF; Seisen T; Abdollah F; Lipsitz SR; Menon M; Kibel AS; Bellmunt J; Choueiri TK; Trinh QD
    Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patients.
    Kayama E; Shigeta K; Kikuchi E; Ogihara K; Hakozaki K; Iwasawa T; Kamisawa K; Kanai K; Ide H; Hara S; Mizuno R; Oya M
    Jpn J Clin Oncol; 2021 Aug; 51(8):1303-1312. PubMed ID: 34009374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.